======= MYBPC3 ======= == Gene Information == * **Official Symbol**: MYBPC3 * **Official Name**: myosin binding protein C3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4607|4607]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14896|Q14896]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MYBPC3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MYBPC3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600958|Open OMIM]] == Function Summary == * **Entrez Summary**: MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3, the cardiac isoform, is expressed exclussively in heart muscle. Regulatory phosphorylation of the cardiac isoform in vivo by cAMP-dependent protein kinase (PKA) upon adrenergic stimulation may be linked to modulation of cardiac contraction. Mutations in MYBPC3 are one cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role. |fn3| |I-set| |C zone| |regulation of muscle filament sliding| |striated muscle myosin thick filament| |cardiac myofibril| |myosin heavy chain binding| |skeletal muscle myosin thick filament assembly| |striated muscle myosin thick filament assembly| |myosin filament assembly| |A band| |myosin filament organization| |skeletal muscle thin filament assembly| |titin binding| |skeletal myofibril assembly| |cardiac muscle fiber development| |striated muscle thin filament| |muscle alpha-actinin binding| |ATPase activator activity| |myosin binding| |cardiac myofibril assembly| |M band| |actin-myosin filament sliding| |muscle filament sliding| |regulation of actin filament-based movement| |structural constituent of muscle| |sarcomere organization| |ventricular cardiac muscle tissue morphogenesis| |sarcomere| |positive regulation of ATPase activity| |ventricular cardiac muscle tissue development| |muscle fiber development| |cardiac muscle cell development| |cardiac cell development| |myofibril assembly| |cardiac muscle tissue morphogenesis| |cardiac ventricle morphogenesis| |cardiac muscle contraction| |muscle tissue morphogenesis| |regulation of ATPase activity| |heart contraction| |muscle organ morphogenesis| |cardiac muscle cell differentiation| |actin-mediated cell contraction| |regulation of striated muscle contraction| |heart process| |cellular component assembly involved in morphogenesis| |striated muscle contraction| |actin filament-based movement| |actomyosin structure organization| |cardiocyte differentiation| |cardiac chamber morphogenesis| |cardiac ventricle development| |Z disc| |striated muscle cell development| |muscle cell development| |regulation of muscle contraction| |cardiac muscle tissue development| |cardiac chamber development| |striated muscle cell differentiation| |actin filament binding| |regulation of muscle system process| |actin filament organization| |muscle cell differentiation| |heart morphogenesis| |muscle contraction| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |muscle system process| |regulation of intracellular transport| |regulation of actin filament-based process| |blood circulation| |circulatory system process| |supramolecular fiber organization| |muscle structure development| |actin cytoskeleton organization| |heart development| |tissue morphogenesis| |actin filament-based process| |regulation of system process| |organelle assembly| |positive regulation of hydrolase activity| |cellular component morphogenesis| |cellular protein-containing complex assembly| |circulatory system development| |anatomical structure formation involved in morphogenesis| |regulation of cellular localization| |cell adhesion| |biological adhesion| |animal organ morphogenesis| |regulation of cellular component movement| |identical protein binding| |cytoskeleton organization| |regulation of hydrolase activity| |positive regulation of catalytic activity| |movement of cell or subcellular component| |protein-containing complex assembly| |cell development| |tissue development| |positive regulation of molecular function| |protein-containing complex subunit organization| |regulation of transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-2.43| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|-2.4| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-2.01| |[[:results:exp273|Cisplatin 0.35μM R06 exp273]]|-1.85| |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|-1.84| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.71| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|1.73| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11935 * **Expression level (log2 read counts)**: -0.82 {{:chemogenomics:nalm6 dist.png?nolink |}}